PulmonxCorp Good Will vs Current Deferred Revenue Analysis
LUNG Stock | USD 8.07 0.31 3.70% |
PulmonxCorp financial indicator trend analysis is much more than just breaking down PulmonxCorp prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether PulmonxCorp is a good investment. Please check the relationship between PulmonxCorp Good Will and its Current Deferred Revenue accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in PulmonxCorp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in PulmonxCorp Stock please use our How to Invest in PulmonxCorp guide.
Good Will vs Current Deferred Revenue
Good Will vs Current Deferred Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of PulmonxCorp Good Will account and Current Deferred Revenue. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between PulmonxCorp's Good Will and Current Deferred Revenue is 0.45. Overlapping area represents the amount of variation of Good Will that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of PulmonxCorp, assuming nothing else is changed. The correlation between historical values of PulmonxCorp's Good Will and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Good Will of PulmonxCorp are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Good Will i.e., PulmonxCorp's Good Will and Current Deferred Revenue go up and down completely randomly.
Correlation Coefficient | 0.45 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Good Will
An intangible asset that arises when a company acquires another business for more than the fair market value of its net identifiable assets, representing the value of the brand, customer base, and other intangible factors.Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.Most indicators from PulmonxCorp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into PulmonxCorp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in PulmonxCorp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in PulmonxCorp Stock please use our How to Invest in PulmonxCorp guide.The PulmonxCorp's current Selling General Administrative is estimated to increase to about 93.9 M, while Tax Provision is projected to decrease to roughly 339.7 K.
PulmonxCorp fundamental ratios Correlations
Click cells to compare fundamentals
PulmonxCorp Account Relationship Matchups
High Positive Relationship
High Negative Relationship
PulmonxCorp fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 53.5M | 263.7M | 235.2M | 193.7M | 179.0M | 94.4M | |
Total Current Liabilities | 14.2M | 12.5M | 17.6M | 18.5M | 23.2M | 24.3M | |
Total Stockholder Equity | (187.4M) | 226.1M | 193.2M | 154.0M | 118.3M | 124.2M | |
Net Tangible Assets | (190.2M) | 223.4M | 190.6M | 151.7M | 174.4M | 183.1M | |
Retained Earnings | (210.5M) | (242.7M) | (291.4M) | (350.3M) | (411.2M) | (390.6M) | |
Accounts Payable | 2.7M | 1.5M | 1.6M | 1.8M | 1.5M | 1.2M | |
Cash | 14.8M | 231.6M | 148.5M | 101.7M | 83.8M | 58.6M | |
Long Term Debt | 15.0M | 17.4M | 17.3M | 17.2M | 35.1M | 36.8M | |
Inventory | 5.6M | 10.7M | 16.3M | 14.6M | 16.7M | 17.6M | |
Total Liab | 240.9M | 37.6M | 41.9M | 39.7M | 60.6M | 61.5M | |
Total Current Assets | 41.1M | 250.0M | 208.0M | 169.0M | 150.3M | 83.2M | |
Short Term Debt | 446K | 2.2M | 2.3M | 3.3M | 5.2M | 5.5M | |
Common Stock | 19K | 36K | 37K | 38K | 39K | 25.0K | |
Property Plant Equipment | 7.5M | 10.5M | 12.9M | 5.3M | 6.1M | 4.1M | |
Net Receivables | 5.9M | 4.2M | 6.6M | 8.7M | 13.4M | 14.1M | |
Other Assets | 2.1M | 536K | 731K | 5.8M | 1.0 | 0.95 | |
Other Current Assets | 766K | 3.2M | 4.9M | 4.3M | 2.8M | 2.0M | |
Intangible Assets | 524K | 400K | 277K | 154K | 31K | 29.5K | |
Short Long Term Debt Total | 21.8M | 27.2M | 26.5M | 24.4M | 41.4M | 32.1M | |
Other Current Liab | 10.9M | 8.7M | 13.5M | 13.3M | 16.3M | 12.6M | |
Other Liab | 43K | 62K | 37K | 94K | 84.6K | 58.1K | |
Property Plant And Equipment Net | 7.5M | 10.5M | 12.9M | 10.5M | 7.4M | 9.0M | |
Current Deferred Revenue | 173K | 71K | 163K | 120K | 104K | 102.7K | |
Net Debt | 7.0M | (204.3M) | (122.0M) | (77.3M) | (42.4M) | (44.5M) | |
Non Current Assets Total | 12.5M | 13.7M | 27.2M | 24.7M | 28.6M | 20.2M | |
Non Currrent Assets Other | 2.1M | 536K | 252K | 5.4M | 3.3M | 2.2M | |
Cash And Short Term Investments | 28.3M | 231.6M | 180.0M | 141.1M | 117.3M | 128.8M | |
Common Stock Total Equity | 19K | 36K | 37K | 38K | 43.7K | 32.3K | |
Common Stock Shares Outstanding | 35.4M | 35.7M | 36.1M | 37.1M | 38.0M | 37.2M | |
Liabilities And Stockholders Equity | 53.5M | 263.7M | 235.2M | 193.7M | 179.0M | 172.3M | |
Non Current Liabilities Total | 226.8M | 25.0M | 24.4M | 21.2M | 37.5M | 67.9M | |
Capital Lease Obligations | 6.8M | 9.9M | 9.0M | 7.1M | 4.2M | 6.8M | |
Other Stockholder Equity | (183.6M) | 467.1M | 482.9M | 502.7M | 526.8M | 333.1M | |
Net Invested Capital | (172.4M) | 243.5M | 210.7M | 171.3M | 155.6M | 87.1M | |
Property Plant And Equipment Gross | 7.5M | 10.5M | 4.8M | 4.7M | 12.3M | 7.3M | |
Accumulated Other Comprehensive Income | 1.4M | 1.7M | 1.7M | 1.6M | 2.6M | 1.9M | |
Capital Stock | 19K | 36K | 37K | 38K | 39K | 34.1K | |
Net Working Capital | 26.9M | 237.5M | 190.5M | 150.5M | 127.3M | 134.9M |
Currently Active Assets on Macroaxis
MSFT | Microsoft | |
GM | General Motors | |
CRM | Salesforce | |
MSFT | Microsoft | |
GOOG | Alphabet Inc Class C |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in PulmonxCorp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in PulmonxCorp Stock please use our How to Invest in PulmonxCorp guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for PulmonxCorp Stock analysis
When running PulmonxCorp's price analysis, check to measure PulmonxCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PulmonxCorp is operating at the current time. Most of PulmonxCorp's value examination focuses on studying past and present price action to predict the probability of PulmonxCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PulmonxCorp's price. Additionally, you may evaluate how the addition of PulmonxCorp to your portfolios can decrease your overall portfolio volatility.
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is PulmonxCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PulmonxCorp. If investors know PulmonxCorp will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PulmonxCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.54) | Revenue Per Share 1.909 | Quarterly Revenue Growth 0.297 | Return On Assets (0.21) | Return On Equity (0.46) |
The market value of PulmonxCorp is measured differently than its book value, which is the value of PulmonxCorp that is recorded on the company's balance sheet. Investors also form their own opinion of PulmonxCorp's value that differs from its market value or its book value, called intrinsic value, which is PulmonxCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PulmonxCorp's market value can be influenced by many factors that don't directly affect PulmonxCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PulmonxCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if PulmonxCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PulmonxCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.